Curis, Inc. (CRIS)
NASDAQ: CRIS · IEX Real-Time Price · USD
14.31
-0.91 (-5.98%)
At close: Apr 19, 2024, 4:00 PM
14.35
+0.04 (0.28%)
After-hours: Apr 19, 2024, 7:54 PM EDT
Curis Market Cap
Curis has a market cap or net worth of $84.34 million as of April 19, 2024. Its market cap has increased by 4.78% in one year.
Market Cap
84.34M
Enterprise Value
30.80M
1-Year Change
4.78%
Ranking
Category
Stock Price
$14.31
Market Cap Chart
Since August 1, 2000, Curis's market cap has decreased from $613.20M to $84.34M, a decrease of -86.25%. That is a compound annual growth rate of -8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 89.70M | -4.57% |
| Apr 17, 2024 | 94.00M | 4.44% |
| Apr 16, 2024 | 90.00M | 4.90% |
| Apr 15, 2024 | 85.80M | -4.77% |
| Apr 12, 2024 | 90.10M | -3.84% |
| Apr 11, 2024 | 93.70M | 4.00% |
| Apr 10, 2024 | 90.10M | -1.85% |
| Apr 9, 2024 | 91.80M | -5.65% |
| Apr 8, 2024 | 97.30M | -1.72% |
| Apr 5, 2024 | 99.00M | 4.87% |
| Apr 4, 2024 | 94.40M | 19.49% |
| Apr 3, 2024 | 79.00M | 8.82% |
| Apr 2, 2024 | 72.60M | -2.81% |
| Apr 1, 2024 | 74.70M | 16.54% |
| Mar 28, 2024 | 64.10M | - |
| Mar 27, 2024 | 64.10M | 7.73% |
| Mar 26, 2024 | 59.50M | -6.74% |
| Mar 25, 2024 | 63.80M | 0.16% |
| Mar 22, 2024 | 63.70M | -0.16% |
| Mar 21, 2024 | 63.80M | 4.76% |
| Mar 20, 2024 | 60.90M | 1.16% |
| Mar 19, 2024 | 60.20M | 0.67% |
| Mar 18, 2024 | 59.80M | -1.48% |
| Mar 15, 2024 | 60.70M | 1.00% |
| Mar 14, 2024 | 60.10M | -0.50% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AlloVir | 85.57M |
| 111, Inc. | 85.19M |
| Connect Biopharma Holdings | 84.86M |
| Seres Therapeutics | 84.55M |
| SHL Telemedicine | 84.42M |
| Reviva Pharmaceuticals Holdings | 84.31M |
| CEL-SCI | 84.21M |
| Protalix BioTherapeutics | 84.01M |